Keyphrases
Cancer Stem Cells
88%
Tumor
51%
Glioblastoma
44%
Variants of Concern
44%
Redox Regulation
44%
Tumor Metastasis
44%
PI-IBS
44%
In Cancer
44%
Tumor Invasion
44%
Cancer Cells
44%
Mild COVID-19
44%
University Staff
44%
Female Presence
44%
SARS-CoV-2 Vaccination
44%
Post-vaccination Antibodies
44%
COVID-19 Patients
44%
3C-like Protease (3CLpro)
44%
Diagnostic Applications
44%
Epithelial-mesenchymal Transition
44%
Cluster of Differentiation 44 (CD44)
44%
SARS-CoV-2 Pneumonia
44%
CD177
44%
Model Identification
44%
Colorectal Cancer
44%
Molecular Pathways
44%
Temozolomide
44%
Mutation Analysis
44%
IDH-wildtype
44%
Radiotherapy
44%
Karnofsky Performance Status
44%
Tumor mutation Burden
44%
CD44v
33%
Mild Patients
29%
Species Evolution
29%
Wuhan
26%
BNT162b2 Vaccine
22%
Microsatellite Instability-high (MSI-H)
19%
BRAF mutation
19%
Delta Variant
17%
PCR Test
14%
Authentic Virus
14%
Pandemic Control
14%
S1 Domain
14%
ACE2 Inhibition
14%
N Protein
14%
Pre-pandemic
14%
Progressive Resistance
14%
Homologous Recombination Proficient
14%
Charles Darwin
14%
Evolution Mechanism
14%
Individual Survival
14%
Biological Observations
14%
Serrated Pathway
12%
Oncogenesis
12%
Mutation Frequency
12%
DNA Damage Response
12%
GSH Synthesis
11%
Cell Surface Markers
11%
Reduced Glutathione
11%
SAP18
11%
Novel Functions
11%
Reactive Oxygen Species
11%
Cystine Transporter
11%
Tumor Microenvironment
11%
Variant Forms
11%
Reactive Oxygen Species Level
11%
Cystine
11%
Glutamate
11%
Function-based
11%
Epithelial Tumor
11%
Intracellular Antioxidants
11%
Beta Variant
8%
Gamma Variant
8%
Non-hazardous
8%
SARS-CoV-2 Variants
8%
D614G
8%
Kappa Variant
8%
Breakthrough Infection
8%
Alpha Variant
8%
Chemotherapy
7%
Cancer Invasion
7%
Pluripotency
7%
Migratory Behavior
7%
Cell Adhesion
7%
Cancer Metastasis
7%
Heterogeneous Cell Population
7%
Biological Significance
7%
Gene mutation
7%
Lymphocyte Doubling Time
7%
Epigenetic Modification
7%
Stem Cell Genes
7%
High-fidelity DNA Polymerase
7%
Indolent Disease
7%
Response Reaction
7%
Vaccine Titer
7%
Cellular Phenotype
7%
Tumor Tissue
7%
SARS-CoV-2 Spike Protein
7%
Between-sex Differences
7%
Non-cancer
7%
Medicine and Dentistry
Cancer Stem Cell
88%
Neoplasm
65%
Severe Acute Respiratory Syndrome Coronavirus 2
48%
Cancer Cell
44%
Metastatic Carcinoma
44%
Stomach Cancer
44%
COVID-19
44%
Prognostic Factor
44%
Glioblastoma
44%
Symptom
44%
Tumor Invasion
44%
Irritable Bowel Syndrome
44%
Gastrointestinal Distress
44%
Mesenchymal-Epithelial Transition
44%
Observational Study
44%
COVID-19 Vaccination
44%
Stomach Tumor
44%
High Salt Diet
44%
Helicobacter Pylori
44%
Tumor Model
44%
Pulmonary Pathology
44%
Infection
44%
Mixed Infection
44%
Gene Expression Profiling
44%
Streptococcus Pneumoniae
44%
Temozolomide
44%
Radiation Therapy
44%
Tumor Mutation Burden
44%
Karnofsky Performance Status
44%
Colorectal Carcinoma
44%
Helicobacter Infection
37%
Carcinogenesis
37%
Rapid Test
31%
Disease
24%
Coronavirinae
24%
Gene Expression
22%
Cystine
22%
Respiratory Failure
22%
Pneumococcal Infection
22%
Pathogen
22%
Diffuse Alveolar Damage
22%
Histopathology
22%
Bronchopneumonia
22%
Reactive Oxygen Species
22%
Diarrhea
20%
Stomach Carcinogenesis
14%
Carcinogen
14%
Microsatellite Instability
14%
Gene Mutation
12%
Nausea
12%
Tumor Microenvironment
11%
Cell Surface Marker
11%
Glutamic Acid
11%
Fallopian Tube
11%
Antioxidant
11%
Glutathione
11%
Epithelioma
11%
Multivariate Analysis
10%
Mutation Rate
9%
APC
9%
DNA Damage Response
9%
Isoprotein
8%
Cell Adhesion Assay
8%
Constipation
8%
Overall Survival
7%
Cell Population
7%
Quantitative Reverse Transcription Polymerase Chain Reaction
7%
Microarray Analysis
7%
Cell Adhesion
7%
Nitrosourea
7%
DNA-directed DNA Polymerase
7%
Glandular Stomach
7%
Solid Malignant Neoplasm
7%
Salt Intake
7%
Tumor Cell
7%
Oligonucleotide
7%
Genomic RNA
6%
Promoter Region
5%
Survival Time
5%
Hydrogen/Deuterium Exchange Mass Spectrometry
5%
Immunology and Microbiology
Severe Acute Respiratory Syndrome Coronavirus 2
100%
COVID-19
88%
CD44
88%
Humoral Immunity
50%
Intron
44%
Cancer Stem Cell
44%
RNA Splicing
44%
Whole Genome Sequencing
44%
Antigen Expression
44%
Prostate
44%
Vaccination Policy
44%
Antibody Titer
44%
Neutralizing Antibody
44%
Cycline
44%
Cell Cycle
44%
Fallopian Tube
44%
Titer
34%
Spike
28%
Vaccine Efficacy
25%
Virus Genome
22%
Monospecific Antibody
22%
Genome Sequencing
22%
Antibody Blood Level
22%
Haplotype
22%
Antibody Response
19%
Receptor Binding
17%
Hydrogen/Deuterium Exchange Mass Spectrometry
14%
RNA Sequencing
11%
Lymphocytopenia
11%
Cell Surface Marker
11%
Gene Expression
11%
Procalcitonin
11%
Serology
11%
Ubiquitins
11%
Chromosome Segregation
11%
Protein Expression
11%
Polymerase Chain Reaction
11%
Virus Neutralization
11%
Proteasome
11%
Cell Cycle Progression
11%
Neutralization
11%
Cell Proliferation
7%
Blood Group A Antigen
7%
DNA Polymerase
7%
Lymphocyte
7%
Leukemia Cell
7%
Western Blot
7%
Breakthrough Infection
6%
Sex Difference
6%